Pharmaceutical Manufacturing
Pharmaceutical Company

How Technology Innovations Are Driving Pharmaceutical Manufacturing?

Manufacturing has been revolutionized by technology. However, pharmaceutical manufacturers are only just beginning to see the potential of innovative product creation. The potential advantages of technology in healthcare are enormous, and breakthrough methodologies are paving the way for a more cost-effective, efficient, and customised approach to drug development. Artificial Intelligence, Machine Learning, AR-VR, Digital Apps, The Internet of Things, Blockchain, 3D printers, and Organ-on-Chips are some of the innovations that are beginning to transform the pharmaceutical industry in the same way they have transformed other industries such as media, retail, banking, telco, and education.

In this article, we will try to shine a light on the areas of the pharmaceutical sector where digital technology will provide the most value, and we will try to steer firms in the right direction as we strive to develop a digital strategy.

We will start with some emerging technologies that are already reshaping the pharmaceutical sector and will continue to do so.

Artificial intelligence and machine learning
Artificial intelligence and machine learning are unquestionably the pharmaceutical industry’s next big thing. Data entry, lab test analyses, data management, analysis of healthcare systems to identify errors or inefficiencies, medical consultations via AI-based apps, medication management that is monitored by an AI-based system, and other repetitive tasks are already being done with AI in the healthcare industry.
Illness identification and diagnosis, radiography and radiation planning, clinical trial research, customized medicine, rare disease identification, and novel medication discovery are all examples of where machine learning is being employed.
Most, if not all, pharmaceutical R&D activities are anticipated to use AI and ML. As a result, the success rate of medication development should theoretically improve, and R&D activities should be streamlined. Furthermore, AI might theoretically aid in precisely identifying the subset of patients who would benefit from a specific medicine. This might significantly lower the failure rate and assure a successful and profitable outcome.
Nonetheless, a shift in present R&D processes is required to get to this position. Rather than attempting to comprehend how AI machines arrive at a solution, the focus should be on confirming the outcomes.

Digitization of Medicine through Healthcare Mobile Apps
Pharma businesses all across the world have recently realized that simply generating and researching pharmaceuticals is no longer enough. They must now go beyond the outward look of medications and provide a full bundle, according to recent trends. Digital health mobile applications, gadgets, or services that might be prescribed by a doctor or packed with a prescription are already known as “around the pill” digital offers.
Some packages include a wearable monitoring gadget and an app, which allows patients to receive positive feedback from their doctors as well as from the app’s automatic, individualized comments. Chronic disease fitness applications, finding free health clinics and hospitals, purchasing prescriptions via e-commerce apps, cross-checking medication interactions, and social network linking patients applications are all popular in app stores.

Furthermore, mobile apps that connect patients with health insurance providers can cut down on the time it takes to authenticate documents and do other verification tasks. In this method, insurance firms obtain prescriptions and other medical documentation from their clients via a mobile app, allowing them to determine whether or not that particular expense is covered by insurance.

AR and VR
As corporations struggle to engage doctors and research schedules spin into a whirlpool of more and more experiments, AR-VR has a lot to offer the pharmaceutical business. AR and VR are promising technologies that can cater to a wide range of pharmaceutical sector demands due to their capacity to build an engaging virtual environment with minute details.
AR-VR can also aid in the pharmaceutical industry’s production area. Remote maintenance and guidance, difficult machine handling training, and so forth are examples. DAQRI, a California-based augmented reality startup, has developed a safety-compliant smart helmet for industrial application. This device exemplifies how successfully augmented reality can be utilized in production, particularly in complicated contexts such as pharmaceutical manufacture.

IoT Integration
The Internet of Things has enormous potential to assist the pharmaceutical business. By recognizing difficulties and making changes before they pose a problem, a network of linked devices with monitoring sensors may decrease the risk of mechanical failures and ensure precise output.
The pharmaceutical industry’s production sector, such as material tracking and management in the manufacturing process of medications, can benefit from IoT integration. Furthermore, IoT-enabled data-gathering devices may be found at shipping and receiving stations, collecting data from RFID tags and barcodes and comparing it to data from other sites, such as manufacturing facilities and warehouses, to ensure consistency.

3D printing innovations
While medicine has long known about the wonders of 3D printing, pharmaceutical production has been slow to catch up. In the medical field, 3D-printed teeth and prostheses are already widely utilized to help patients. However, there are few FDA-approved 3D-printed medicinal goods on the market in the United States.
While having a 3D printer at your local pharmacy may seem futuristic, the notion of additive pharmaceutical production is propelling the industry toward a future where each patient’s disease may be treated uniquely.

Accelerated automation
When it comes to innovation, the pharmaceutical sector turns outside of itself for ideas. Automation has, of course, played a significant role in the industry for almost a century. Automation is utilized in the automotive industry, for example, to cut costs and handle more complex operations. Pharma companies are now attempting to do the same.

Previously, scientists were stymied by the time-consuming effort of performing individual genomic tests. Manufacturers, on the other hand, may now access a massive quantity of data, allowing them to construct unique molecular profiles of their clients and give them individualized treatment.

Conclusion
The drug research business is always growing and developing to generate new treatments for a range of indications, and technologies like artificial intelligence and automation are a big part of that.

pharmaceutical companies in Nigeria
pharmaceutical exporters

Developing Pharmaceutical Industry in Africa

The African pharmaceutical market is developing at a rapid speed due to changing economic profiles, growing investment in healthcare, rapid urbanization, and increase in chronic lifestyle diseases. In 2013, the pharmaceutical industry’s value touched $20.8 billion. Multinational pharma companies got a good chance to boost and expand their business. Also, patients gained access to world-class medicines that were not available earlier.

The tropical climate is responsible for various infectious diseases:

The continent encounters infectious diseases like tuberculosis, malaria, AIDs, polio, cholera, yellow fever, meningitis, pandemic influenza, hepatitis, measles, tetanus, etc. There is a visible shift towards non-communicable diseases due to the growing adoption of western lifestyle in Africa, Nigeria, etc.

The pharmaceutical companies in Nigeria, Africa, etc. are manufacturing and importing generic and prescription drugs from other countries. Certain lifestyle diseases including cancer, cardiovascular ailments, diabetes, etc. are growing at a high rate. According to the prediction of the World Health Organization, the NCDs’ proportional contribution to the healthcare burden in these nations will grow by 21% by 2030.

The transitional phase of Africa and Nigeria:

Currently, the nations are in a transitional phase. They are looking forward and working hard towards adherence to certain global standards like the WHO pre-qualification to manufacture. Local production by the top 20 pharmaceutical companies in Nigeria, Africa, etc. is considered as the main strategy for persistent access to high-quality medicines for the long term.

Again, the regulatory environment for medicine production in East Africa is rapidly growing due to the regional harmonization. Experts are expecting expansion of healthcare coverage to a greater number of people through the initiatives of National Health Insurance and through memberships with providers of Private Health Insurance.

The rising popularity of generic medicines:

Generic drugs are getting more market share in Nigeria, South Africa, Kenya, Algeria, Egypt, and Morocco. Between the year 2010 and 2014, the share of generic drugs’ market raised from 22 to 25 percent in Algeria. In Morocco, the rise was from 23 to 28 percent. The pharmaceutical exporters in Africa are finding various factors.

  • The pharmacists and physicians are getting habituated to prescription drugs.
  • There is an expansion of national insurance programs.
  • Many people are gaining access to modern healthcare.
  • The demands for generic drugs are growing instead of costly branded medicines.
  • Governments are displaying strong support for generic medicines. In South Africa, pharmacists are informing private patients about these medicines while they are buying prescription drugs. Again, Nigeria is also following similar law.

 

The business environment is changing:

Governments have taken various initiatives like introducing price controls, import restrictions to give way to the manufacturing of domestic drugs. Country-specific labelling is required for reduction of parallel imports and counterfeiting. Again, the government has initiated stricter laws on import, retail margins and wholesale.

Pharma manufacture in Nigeria, Africa and other locations is on a steady rise. Several joint ventures, partnerships, merging, strategic alliances and private-equity deals are taking place and expanding the present market.

Presently, South Africa is the most superior region for products of medicines in Sub-Saharan Africa. The local market of pharmaceutical manufacturing in East and West Africa are likely to develop. Majority of Africa-based pharmaceutical firms are producing medicines having simple mixtures and formulations.

Technological development is crucial for the development of the manufacturing sector in Nigeria and Africa mainly due to the change in disease burden. Nowadays, the nations are adopting complex formulations aligning with treatment guidelines related to AIDS, HIV, and NCDs.

Grounds of the pharmaceutical industry in African countries:

The pharmaceutical markets in African countries are growing in all sectors. In the recent past till last year, there was a steady growth of prescription drugs, generic medicines, over the counter medicines and lots of medical devices.

The driving grounds are:

Speedy urbanization: The population of Africa is currently passing through a tremendous shift. It is estimated that by the year 2025, around two-fifth of the total economic growth will arrive from 30 cities that consist of around 2 million people. Again, 22 of these cities can have excess GDP of around $20 billion. These cities are likely to enjoy better healthcare and logistics infrastructure. The urban people have more buying capabilities and they can adopt modern best-in-class medicines.

The infrastructure of healthcare: Africa has added 70,000 hospital beds, 16,000 good doctors and 60,000 trained nurses between 2005 and 2012. The provision of healthcare is becoming more methodical via various initiatives. Moreover, the origination of avant-garde delivery models is boosting the capacity.

African pharma market has a better future:

Africa is not a single unified market. It is consisting of 54 distinct markets embracing wide gaps between countries in respect to a growth trajectory, market size, legal structure, macroeconomic landscape, and political complexities. The number of households interested in consuming world-class medicines is increasing. Hence, the pharmaceutical companies in Nigeria and pharmaceutical exporters in Africa are focusing on providing more quality medicines to all.

Make a Call: +91 9979382527
Mail us at [email protected]

CALL ME BACK